These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35518121)

  • 1. Efficacy and safety of vibrating capsule for functional constipation (VICONS): A randomised, double-blind, placebo-controlled, multicenter trial.
    Zhu JH; Qian YY; Pan J; He C; Lan Y; Chen WN; Wang BM; Zhao W; Li JN; Li XQ; Lv B; Fan YH; Zuo XL; Li Z; Zou DW; Li ZS; Liao Z
    EClinicalMedicine; 2022 May; 47():101407. PubMed ID: 35518121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized Placebo-Controlled Phase 3 Trial of Vibrating Capsule for Chronic Constipation.
    Rao SSC; Quigley EMM; Chey WD; Sharma A; Lembo AJ
    Gastroenterology; 2023 Jun; 164(7):1202-1210.e6. PubMed ID: 36822371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
    Schoenfeld P; Lacy BE; Chey WD; Lembo AJ; Kurtz CB; Reasner DS; Bochenek W; Tripp K; Currie MG; Fox SM; Blakesley RE; OʼDea CR; Omniewski ND; Hall ML
    Am J Gastroenterol; 2018 Jan; 113(1):105-114. PubMed ID: 29091082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of the sodium-glucose cotransporter 1 inhibitor mizagliflozin for functional constipation: a randomised, placebo-controlled, double-blind phase 2 trial.
    Fukudo S; Endo Y; Hongo M; Nakajima A; Abe T; Kobayashi H; Nakata T; Nakajima T; Sameshima K; Kaku K;
    Lancet Gastroenterol Hepatol; 2018 Sep; 3(9):603-613. PubMed ID: 30056028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of MaZiRenWan, a Chinese Herbal Medicine, in Patients With Functional Constipation in a Randomized Controlled Trial.
    Zhong LLD; Cheng CW; Kun W; Dai L; Hu DD; Ning ZW; Xiao HT; Lin CY; Zhao L; Huang T; Tian K; Chan KH; Lam TW; Chen XR; Wong CT; Li M; Lu AP; Wu JCY; Bian ZX
    Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1303-1310.e18. PubMed ID: 29654915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial.
    Nakajima A; Seki M; Taniguchi S; Ohta A; Gillberg PG; Mattsson JP; Camilleri M
    Lancet Gastroenterol Hepatol; 2018 Aug; 3(8):537-547. PubMed ID: 29805116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
    Loncharich MF; Anderson CW
    ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of vibrating capsules for functional constipation: a systematic review and meta-analysis of randomized controlled trials.
    Saeed A; Abuelazm MT; Abdelnabi M; Elewidi M; Khaled A; Elzahaby A; Mousa A; Abdelazeem B
    Curr Med Res Opin; 2023 Sep; 39(9):1195-1204. PubMed ID: 37526021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation.
    Mueller-Lissner S; Kamm MA; Wald A; Hinkel U; Koehler U; Richter E; Bubeck J
    Am J Gastroenterol; 2010 Apr; 105(4):897-903. PubMed ID: 20179697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.
    Chey WD; Lembo AJ; Lavins BJ; Shiff SJ; Kurtz CB; Currie MG; MacDougall JE; Jia XD; Shao JZ; Fitch DA; Baird MJ; Schneier HA; Johnston JM
    Am J Gastroenterol; 2012 Nov; 107(11):1702-12. PubMed ID: 22986437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation.
    Rao S; Lembo AJ; Shiff SJ; Lavins BJ; Currie MG; Jia XD; Shi K; MacDougall JE; Shao JZ; Eng P; Fox SM; Schneier HA; Kurtz CB; Johnston JM
    Am J Gastroenterol; 2012 Nov; 107(11):1714-24; quiz p.1725. PubMed ID: 22986440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenapanor Treatment of Patients With Constipation-Predominant Irritable Bowel Syndrome: A Phase 2, Randomized, Placebo-Controlled Efficacy and Safety Trial.
    Chey WD; Lembo AJ; Rosenbaum DP
    Am J Gastroenterol; 2017 May; 112(5):763-774. PubMed ID: 28244495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of vibrating capsule in treatment of chronic idiopathic constipation: a systematic review and meta-analysis of randomized controlled trials.
    Haghbin H; Zakirkhodjaev N; Gangwani MK; Beran A; Lee-Smith W; Piper MH; Aziz M
    Transl Gastroenterol Hepatol; 2024; 9():8. PubMed ID: 38317751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the vibrating capsule on colonic circadian rhythm and bowel symptoms in chronic idiopathic constipation.
    Rao SSC; Lembo A; Chey WD; Friedenberg K; Quigley EMM
    Neurogastroenterol Motil; 2020 Nov; 32(11):e13890. PubMed ID: 32449277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for preventing postpartum constipation.
    Turawa EB; Musekiwa A; Rohwer AC
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD011625. PubMed ID: 26387487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of lubiprostone for the treatment of functional constipation in Chinese adult patients: A multicenter, randomized, double-blind, placebo-controlled trial.
    Xiao YL; Dai N; He SX; Tian A; Liu S; Tian ZB; Wang XY; Li YQ; Hou XH; Fang XC; Wen ZL; Zeng WZ; Xu H; Sun MJ; Liu YL; Wu YD; Shen XZ; Liu XW; Liu L; Chen MH
    J Dig Dis; 2021 Nov; 22(11):622-629. PubMed ID: 34633753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of electroacupuncture versus prucalopride for women with severe chronic constipation: secondary analysis of a randomized controlled trial.
    Wang X; Sun Y; Yan S; Shi H; Zhu L; Gao S; Liu Z
    Int J Colorectal Dis; 2023 Jan; 38(1):20. PubMed ID: 36662303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of a New Smartphone-controlled Vibrating Capsule on Defecation in Beagles.
    Yu J; Qian YY; He CH; Zhu SG; Zhao AJ; Zhu QQ; Shao CW; Wang TG; Wang Y; Ding GL; Liao Z; Li ZS
    Sci Rep; 2017 Jun; 7(1):2841. PubMed ID: 28588191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining an optimal dose of linaclotide for use in Japanese patients with irritable bowel syndrome with constipation: A phase II randomized, double-blind, placebo-controlled study.
    Fukudo S; Nakajima A; Fujiyama Y; Kosako M; Nakagawa A; Akiho H; Nakashima Y; Johnston JM; Miwa H
    Neurogastroenterol Motil; 2018 May; 30(5):e13275. PubMed ID: 29278278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Kivia powder on gut health in patients with occasional constipation: a randomized, double-blind, placebo-controlled study.
    Udani JK; Bloom DW
    Nutr J; 2013 Jun; 12():78. PubMed ID: 23758673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.